Jayshree Chemicals Ltd (506520)

Chemicals · Chemicals · NSE · Updated 1 September 2026
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
₹5.8 ↓ 21.73% (1Y)

🎯 Key Takeaways

  • Jayshree Chemicals Ltd is in a structural decline phase, marked by persistent losses, negative ROE, and shrinking operational scale. The company has reported consecutive quarterly losses with deteriorating margins and minimal revenue stability, indicating a non-recovery trajectory rather than a temporary downturn.
  • Revenue declined 9.4% QoQ to ₹3 in Q3FY24.
  • ⚠️ 1) Chronic un profitability with no visible path to breakeven, 2) Heavy reliance on volatile chemical demand with no customer diversification disclose
Market Cap
₹17
P/B Ratio
1.22
ROE
-0.6%
Debt/Equity
0.29
Promoter
46.3%

📖 The Story

Jayshree Chemicals Ltd is in a structural decline phase, marked by persistent losses, negative ROE, and shrinking operational scale. The company has reported consecutive quarterly losses with deteriorating margins and minimal revenue stability, indicating a non-recovery trajectory rather than a temporary downturn.

📰 What's Happening

Management has not announced any new capacity expansions or order wins in recent filings. The only operational update was a minor product mix shift in Q3FY26, which failed to improve profitability. There has been no mention of restructuring, cost-cutting initiatives, or new customer acquisition strategies in the latest BSE filings. The company continues to operate at a loss without visible signs of stabilization.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

MetricMar 2023Jun 2023Sep 2023Dec 2023
Revenue3343
Operating Profit-0-00-0
OPM %-12.6%-11.9%0.8%-10.7%
Net Profit-000-0
EPS₹-0.01₹0.00₹0.05₹-0.06

Revenue has remained flat around ₹3-4 crore per quarter over the past year, but operating margins have worsened from -0.8% in Sep 2023 to -12.6% in Mar 2023, reflecting rising input costs or pricing pressure with no offsetting efficiency gains. Net losses have deepened slightly despite stable top-line, suggesting deteriorating cost control. The absence of any recovery guidance implies this trend is expected to persist.

🔮 Management Outlook & What's Next

There is no forward guidance or strategic outlook provided in the latest filings. Management has not addressed the profitability crisis in recent shareholder communications, and no turnaround plan has been disclosed. The last commentary focused solely on routine compliance and regulatory updates, with no mention of corrective actions or performance targets.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

ItemMar 2022Mar 2023Mar 2023Mar 2024
Equity Capital29292929
Reserves-13-14-15-15
Borrowings0041
Total Liabilities23232522
Fixed Assets3333
Investments0000
Total Assets23232522

The balance sheet shows a stable but minimal equity base with negative reserves indicating cumulative losses. Borrowings have declined slightly from ₹4 crore to ₹1 crore, suggesting modest deleveraging, but total assets have contracted from ₹25 crore to ₹22 crore, reflecting asset reduction without corresponding liability reduction. There is no evidence of capital expenditure or strategic investment activity.

💰 Cash Flow Statement (₹ Cr)

ItemMar 2023
Operating-2
Investing+1
Financing+0
Net Cash Flow-1

👥 Shareholding Pattern

CategoryQ2FY26Q3FY26Q4FY26Q1FY27
Promoters46.3%46.3%46.3%46.3%
FII0.0%0.0%0.0%0.0%
DII0.0%0.0%0.0%0.0%
Public49.9%49.7%49.7%49.5%
# Shareholders10,90010,79410,64610,554

Promoter holding remains unchanged at 46.27%, but institutional interest has collapsed — FII and DII holdings are effectively zero, with DII at just 0.02% for over a year. The shrinking shareholder base and rising retail count suggest speculative interest but no institutional confidence. No insider buying or stake increases have been reported.

⚖️ Peer Comparison — Chemicals

Company MCap (₹ Cr) P/E ROCE ROE D/E
PIDILITIND 1.67 L Cr 63.2 33.4% 24.7% 0.01
SRF 75,831 35.1 15.6% 15.4% 0.36
LINDEINDIA 54,443 99.7 17.5% 12.8% 0.00
FLUOROCHEM 51,528 84.2 9.6% 7.7% 0.34
NAVINFLUOR 44,502 56.3 22.2% 19.9% 0.31
GODREJIND 38,256 32.5 9.2% 19.8% 4.57
HSCL 33,181 41.2 20.7% 17.1% 0.16
DEEPAKNTR 23,850 30.4 15.3% 13.4% 0.26
AETHER 22,459 95.2 13.8% 10.6% 0.08
AARTIIND 19,021 35.8 9.2% 9.5% 0.68

⚠️ Risk Factors

1) Chronic un profitability with no visible path to breakeven, 2) Heavy reliance on volatile chemical demand with no customer diversification disclosed, 3) Negative equity reserves eroding financial buffers, 4) Absence of management communication or action plan to address structural losses.

🧠 Analyst's Read

The company is in a terminal decline phase with no catalysts in sight. Investors should monitor for any signs of operational restructuring or management change, but current disclosures suggest no intervention is forthcoming. Continued losses and zero institutional ownership make the stock highly speculative with asymmetric downside risk.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

Sign Up Free — Unlock Full Analysis

2 free AI queries per day.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-01.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts for your stocks — summarized by AI daily

Set up your AI Radar — pick stocks, get daily email summaries of new filings.

Set up AI Radar — Free

Free account · 2 AI queries/day